Pathology of hepatocellular carcinoma

被引：1
|
作者：
Longerich, Thomas [1 ]
Schirmacher, Peter [1 ]
机构：
[1] Heidelberg Univ, Pathol Inst, Univ Klinikum Heidelberg, Neuenheimer Feld 224, D-69120 Heidelberg, Germany
来源：
PATHOLOGE | 2022年 / 43卷 / 01期
关键词：
Liver cancer; Liver biopsy; Histology; Hepatocarcinogenesis; Molecular pathology; GLUTAMINE-SYNTHETASE; DOUBLE-BLIND; EXPRESSION; DIAGNOSIS; SORAFENIB; HSP70; IDENTIFICATION; GLYPICAN-3; INVASION; SUBTYPE;
D O I：
10.1007/s00292-021-01038-0
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Hepatocellular carcinoma (HCC) represents the third leading cause of cancer-related mortality worldwide and has a well-defined etiology. It develops in a stepwise process with morphologically defined precursor lesions. Typing of highly differentiated hepatocellular tumors is supported by immunohistological marker panel and the so-called matrix diagnosis. The recent World Health Organization (WHO) classification defined morpho-molecular HCC subtypes showing typical clinical and prognostic characteristics. If HCC subtyping is considered in future clinical studies of advanced HCC, this could help to introduce personalized HCC therapy. Currently, precision oncology is not available for HCC.
引用
收藏
页码：67 / 78
页数：12
相关论文
共 50 条
  • [21] Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology
    Rao, Guocheng
    Peng, Xi
    Tian, Yan
    Fu, Xianghui
    Zhang, Yuwei
    FRONTIERS IN GENETICS, 2023, 14
  • [22] Pathology of Early Hepatocellular Carcinoma: Conventional and Molecular Diagnosis
    Roskams, Tania
    Kojiro, Masamichi
    SEMINARS IN LIVER DISEASE, 2010, 30 (01) : 17 - 25
  • [23] Downstaging Hepatocellular Carcinoma: An Evaluation of Explant Pathology and Outcomes
    Peck, Arika L.
    Schnickel, Gabriel
    Abouljoud, Marwan
    Yoshida, Atsushi
    Kim, Dean
    Kasimi, Marwan
    Bruno, David
    Antoine, Heath
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 90 - 90
  • [24] Hepatocellular carcinoma: Therapeutic intervention and outcome - A pathology perspective
    Buza, N
    Regenstein, F
    Dash, S
    Haque, S
    MODERN PATHOLOGY, 2005, 18 : 276A - 276A
  • [25] Hepatocellular carcinoma: Therapeutic intervention and outcome pathology perspective
    Buza, N
    Regenstein, F
    Dash, S
    Haque, S
    LABORATORY INVESTIGATION, 2005, 85 : 276A - 276A
  • [26] Hepatocellular Carcinoma With Atypical Imaging Features: Review of the Morphologic Hepatocellular Carcinoma Subtypes With Radiology-Pathology Correlation
    Bello, Hernan R.
    Mahdi, Zaid K.
    Lui, Shu K.
    Nandwana, Sadhna B.
    Harri, Peter A.
    Davarpanah, Amir H.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2022, 55 (03) : 681 - 697
  • [27] Reflections on prediction of microvascular invasion in hepatocellular carcinoma by pathology images
    Cai, Wen-Tao
    Shen, Ning-Zhe
    Lu, Yang-Bin
    Huang, Jian-Qiang
    Jiang, Zhi-Xuan
    Chen, Xiao-Dong
    HEPATOLOGY INTERNATIONAL, 2023, 17 (02) : 514 - 515
  • [28] Pathology of early hepatocellular carcinoma - Progression from early to advanced
    Kojiro, M
    HEPATO-GASTROENTEROLOGY, 1998, 45 : 1203 - 1205
  • [29] Neutrophils are key immunological players in the pathology and therapy of hepatocellular carcinoma
    Mann, Derek
    JOURNAL OF PATHOLOGY, 2023, 261 (SUPPL1): : S9 - S9
  • [30] Anatomic Pathology of Hepatocellular Carcinoma: Impact on Prognosis and Response to Therapy
    Roskams, Tania
    CLINICS IN LIVER DISEASE, 2011, 15 (02) : 245 - +
12345